Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Treatment of Cutaneous Leishmaniasis With Meglumine Antimoniate Versus Meglumine Antimoniate and Allopurinol

This study has been completed.
Sponsor:
Information provided by:
Combined Military Hospital, Pakistan
ClinicalTrials.gov Identifier:
NCT00480883
First received: May 29, 2007
Last updated: June 1, 2010
Last verified: May 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2008
  Primary Completion Date: June 2008 (Final data collection date for primary outcome measure)